Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sheng Ling
- Development stage
- Preclinical
- Lead developer
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Sheng Ling (also known as Shenqi Yiqi Shengxue mixture) is a traditional Chinese medicine (TCM) hospital preparation developed by the Yueyang Hospital of Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is formulated with several herbal ingredients, including Astragalus membranaceus (Huangqi), Codonopsis pilosula (Dangshen), Rehmannia glutinosa (Dihuang), Prepared Rehmannia root (Shudihuang), Salvia miltiorrhiza (Danshen), Atractylodes macrocephala (Baizhu), and Angelica sinensis (Danggui). Sheng Ling is primarily used to treat chronic immune thrombocytopenia (ITP), particularly refractory cases, by promoting platelet production, regulating immune function, and controlling bleeding. It is often evaluated in combination with low-dose corticosteroids (such as prednisone) to improve efficacy and safety in patients with refractory chronic ITP.
- Other names
- Shenqi Yiqi ShengxueShenqi Yiqi Shengxue decoctionShenqi Yiqi Shengxue mixtureshengxueling参芪益气生血合剂
Beyond the preview
Go deeper on Sheng Ling.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sheng Ling.